MED‑Project is a subsidiary established by the Pharmaceutical Product Stewardship Work Group (PPSWG) to develop, implement, and operate safe, effective, compliant programs for the disposal of household pharmaceutical products in adherence with state and local legislation. MED‑Project is a non-profit, 501(c)(3) tax-exempt organization.
Visit the PPSWG website to learn more about the work of PPSWG or if you are a producer interested in joining the association.
Working as an accountable organization, on behalf of producers, MED‑Project effectively operates take-back programs for unwanted medications and sharps from households.
MED‑Project’s programs are designed and operated to meet all applicable program requirements and federal, state, and local laws and regulations, providing comprehensive compliance systems and risk mitigation across all mandated jurisdictions.
MED‑Project executes on its purpose to provide safe, secure, cost-effective, take-back programs for unwanted pharmaceutical products from households, delivering compliant programs for producers.
Collection & Disposal
Outreach & Education
Board of Directors
MED‑Project’s governing bodies monitor the performance and quality compliance of all pharmaceutical product stewardship programs.
The Board of Directors is appointed by the Pharmaceutical Product Stewardship Work Group Board of Directors to represent the collective’s interests and provide governance and oversight to the compliance, financial strategies, operations, and regulatory affairs executed by MED‑Project.
Stacy Burch – Chair
Vice President, North America Marketing
Rachel Young – Vice Chair
Ray Sharples – Past Chair
Senior Manager, Environmental Product Compliance, Governance, and Strategy
Johnson & Johnson
Director, Returns Processing and Rebate Support
Global Director, Environmental Compliance & Remediation
Sr. Director, State Government Relations
Senior Director - US Public Policy
Eli Lilly and Company
Global Director EHS
Manager, Environment, Corporate
MED‑Project leadership manages the compliance, financial implementation, and operations of the pharmaceutical product stewardship plans.
Michael Van WinkleMS, CIH
Lead Director of Finance and Administration
Dr. Victoria TravisPharmD, MS, MBA
National Program Director
Jim WilsonJD, MS, MSM, P.E.
Lead Director of Compliance and Risk Management
Adam BurkhardtMS, PMP, PMI-ACP
Senior Director, Data Services & Project Management Center of Excellence
Delivering on Priorities
- Detailed implementation and compliance plans to meet all the requirements of each unique jurisdiction
- Brand-safe outreach and education materials
- Cost-effective compliance and implementation